Obesity References

 

1. Mokdad AH, et al. "The Spread of the Obesity Epidemic in the United States, 1991-1998." Journal of the American Medical Association. 282:1519-1522, 1999.
 

2. "AHA Dietary Guidelines Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association." Circulation 2000 Oct 31;102(18):2284-99.
 

3. National Center for Health Statistics: Overweight Prevalence:
http://www.cdc.gov/nchs/fastats/overwt.htm
 

4. Ceci S et al. The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects. J Neural Transm 1989 (76): 109-17.
 

5. Cangiano C et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr 1992 (56): 863-67.
 

6. Cangiano C, et al. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients. Int J Obes Relat Metab Disord. Jul1998;22(7):648-54.
 

7. Vincent JB. Mechanisms of chromium action: low-molecule-weight chromium-binding substance. J Am Coll Nutr. 1999;18(1):6-12.
 

8. Anderson RA. Chromium as an essential nutrient for humans. Regul Toxicol Pharmacol. 1997;26:S35-S46.
 

9. Evans GW et al. Composition and biological activity of chromium-pyridine carbosylate complexes. J Inorganic Biochemistry 1993 (49): 177-87.
 

10. Bahadori B, Wallner S, Schneider H, et al. [Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet]. Acta Med Austriaca. 1997;24(5):185-7.
 

11. Kalix P. The pharmacology of psychoactive alkaloids from ephedra and catha. J Ethnopharmacol. Apr1991;32(1-3):201-8.
 

12. Astrup A et al. Pharmacology of thermogenic drugs. Am J Clin Nutr 1992 55 (1 Suppl): 246S-248S.
 

13. Gurley BJ, et al. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography. J Pharm Sci. 1998 Dec;87(12):1547-53.
 

14. White LM, et al. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol. Feb1997;37(2):116-22.
 

15. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 689
 

16. Pasquali R. A controlled trial using ephedrine in the treatment of obesity. Int J Obes 1985 (9): 93-98.
 

17. Astrup A, et al. Pharmacological and clinical studies of ephedrine and other thermogenic agonists. Obes Res. Nov1995;(3 Suppl 4):537S-540S.
 

18. Ramsey JJ, et al. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine. Am J Clin Nutr. Jul1998;68(1):42-51.
 

19. Buemann B, et al. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet. Int J Obes Relat Metab Disord. May1994;18(5):329-32.
 

20. Toubro S et al. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. Int J Obes 1993 17 (Suppl.1): S69-72.
 

21. Astrup A. et al. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Metabolism 1992 (41): 686-88.
 

22. Glennon RA, et al. (+)Amphetamine-stimulus generalization to an herbal ephedrine product. Pharmacol Biochem Behav. Apr2000;65(4):655-8.
 

23. Gurley BJ, et al. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography. J Pharm Sci. 1998 Dec;87(12):1547-53.
 

24. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 693
 

25. Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev. 2001 May;59(5):129-39.
 

26. Krotkiewski M. Effect of guar on body weight, hunger ratings and metabolism in obese subjects. Clinical Science 1984 (66): 329-36.
 

27. Rossner S et al. Weight reduction with dietary fibre supplements. Results of two double-blind studies. Acta Med Scand 1987 (222): 83-88.
 

28. Ryttig KR et al. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial. Int J Obesity 1989 (14): 763-69.
 

29. Rigaud D et al. Mild overweight treated with energy restriction and a dietary fiber supplement: a 6-month randomized, double blind, placebo-controlled long-term trial. Int J Obesity 1990 (14):764-69
 

30. Nityanand S et al. Clinical trials with gugulipid, a new hypolipidaemic agent. J Assoc Physicians India 1989 (37): 321-8.
 

31. Heymsfield SB, et al. Garcinia cambogia (hydroxycitric acid) as a Potential Anti-obesity Agent: A Randomized Controlled Trial. JAMA. Nov1998;280(18):1596-600.
 

32. Sullivan AC, et al. Metabolic regulation as a control for lipid disorders. II. Influence of (--)-hydroxycitrate on genetically and experimentally induced hypertriglyceridemia in the rat. Am J Clin Nutr. 1977 May;30(5):777-84.
 

33. Yamasaki M, et al. Dietary effect of conjugated linoleic acid on lipid levels in white adipose tissue of Sprague-Dawley rats. Biosci Biotechnol Biochem. Jun1999;63(6):1104-6.
 

34. Gaullier JM, Halse J, Hoye K, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr. Jun2004;79(6):1118-25.
 

35. West DB, et al. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol. Sep1998;275(3 Pt 2):R667-72.
 

36. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 333
 

37. Shilo S, et al. Iodine-induced hyperthyroidism in a patient with a normal thyroid gland. Postgrad Med J. Jul1986;62(729):661-2.
 

38. Baba N et al. Enhanced thermogenesis and diminished deposition of fat in response to overfeeding with diet containing medium chain triglyceride. Am J Clin Nutr 1982 (35): 678-82.
 

39. Hill JO et al. Thermogenesis in man during overfeeding with medium chain triglycerides. Am J Clin Nutr 1989 (38): 641-48.
 

40. Life Extension eds., Disease Prevention and Treatment, 4th ed. Florida: Life Extension Media, 2003.
 

Return to Obesity Introduction